China Animal Healthcare, one of the leading animal drug manufacturers in the country, says it will list by way of introduction on the Mainboard of The Stock Exchange of Hong Kong.

“The Hong Kong listing of the Company does not involve any sale or allotment of shares or other securities of or by the Company to the public,” says the company in an SGX statement.

Macquarie Capital Securities has been appointed sole sponsor of the listing.

China Animal Healthcare is expected to trade on the HKEx at 9:30 am (Hong Kong time) tomorrow.